Clinical Focus: UK Radiopharmaceuticals Market Indication
The UK Radiopharmaceuticals Market Indication is dominated by Oncology, reflecting the increasing prevalence of cancer and the pivotal role of nuclear medicine in the diagnosis, staging, and now targeted treatment of many tumor types. Over 60% of nuclear imaging procedures are related to cancer care, with high-demand driven by tracers for lung, prostate, and breast cancer. The second largest...
0 Comments 0 Shares 365 Views 0 Reviews